Science Explorer Back to mapMap
Discussion
Researcher · Masaryk Memorial Cancer Institute · Czechia

N Hejlová

N Hejlová publishes mostly in Molecular Biology, Genetics and Pathology and Forensic Medicine, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Chronic Lymphocytic Leukemia Research and Chemotherapy-induced organ toxicity mitigation.

OpenAlex
World rank
#7,189,980
of 7,710,434 ranked researchers
Rank in Czechia
#33,266
of 39,303
Works
33
Citations
52
Citations per work
1.6
h-index
4
i10-index 1Top 98% in Molecular Biology
N Hejlová

What does N Hejlová research?

N Hejlová's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 19 works · 56.1% of their workMedicine: 19 works · 56.1% of their workGenetics: 5 works · 15.3% of their workPathology and Forensic Medicine: 4 works · 13.6% of their workOncology: 4 works · 11.9% of their workHematology: 3 works · 10.2% of their workEpidemiology: 2 works · 5.1% of their workEverything else: 9 works · 28.6% of their workLife Sciences: 5 works · 15.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 15.3% of their workMolecular Biology: 5 works · 15.3% of their workTHEIR WORKN Hejlová33works
Life Sciences15%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1956.1%
  2. Everything else928.6%
    1. Biochemistry, Genetics and Molecular Biology515.3%
  1. 1Molecular Biology15% of their works
  2. 2Genetics15% of their works
  3. 3Pathology and Forensic Medicine14% of their works
  4. 4Oncology12% of their works
  5. 5Hematology10% of their works
  6. 6Epidemiology5% of their works

Research topics

Which keywords describe N Hejlová's research?

The keywords of their largest research topics: Rituximab, Cardiac Amyloidosis, Transthyretin, Chronic Lymphocytic Leukemia, Cisplatin, Genomic Aberrations, Nephrotoxicity and Chemotherapy-Induced Peripheral Neuropathy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Rituximab72 topics
  2. Cardiac Amyloidosis51 topic
  3. Transthyretin51 topic
  4. Chronic Lymphocytic Leukemia41 topic
  5. Cisplatin41 topic
  6. Genomic Aberrations41 topic
  7. Nephrotoxicity41 topic
  8. Chemotherapy-Induced Peripheral Neuropathy31 topic
  9. Classification31 topic
  10. Diagnosis Criteria31 topic
  11. International Myeloma Working Group31 topic
  12. JAK2 Mutation31 topic
  13. Lymphoma31 topic
  14. Myelofibrosis31 topic
  15. Taxanes31 topic
  16. Sickle-cell Disease21 topic
  17. Thalassemia21 topic

Where does N Hejlová work?

N Hejlová's main affiliation in the publication record is Masaryk Memorial Cancer Institute, Czechia.

How many publications and citations does N Hejlová have?

OpenAlex counts 33 works and 52 citations for N Hejlová, an h-index of 4, ranking #7,189,980 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about N Hejlová. Posts are plain text and can be reported.